Literature DB >> 6872867

Skin irritation by topical drugs.

A Zesch.   

Abstract

In order to develop topical drugs aside from galenic problems, there should be considerations how the skin could be made permeable. For the purpose of receiving an topical basis which favours penetration, ingredients known as auxiliary agents are used, which themselves have an effect on the horny layer and therefore impair the barrier function. The horny layer is irritated to a varying extent due to the chemical and physical properties of such substances. While the concentration of the active ingredients in the epidermis is improved, the irritation of the horny layer must be accepted. When using corticoids this fact may be misconstrued for lacking efficacy. Although auxiliary agents like polyethylene glycol, propylene glycol, o/w emulsifiers, alcohols or acetone show various effects on the horny layer, they all cause dehydration. Experimental data show that for propylene glycol this is clearly concentration related. Other only rarely used solvents like DMSO or dimethyl acetamide have properties directly altering the structure of the horny layer. Even topically applied ingredients only partially show the desired direct or indirect irritative effect on the horny layer. This is true for substances reacting directly with keratin as well as for substances which exhibit cytostatic or cytotoxic effects on the epidermis and for substances that lead to skin irritation. A risk/benefit evaluation is under discussion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6872867

Source DB:  PubMed          Journal:  Derm Beruf Umwelt        ISSN: 0343-2432


  2 in total

Review 1.  Federal government regulation of occupational skin exposure in the USA.

Authors:  Mark F Boeniger; Heinz W Ahlers
Journal:  Int Arch Occup Environ Health       Date:  2003-05-29       Impact factor: 3.015

Review 2.  Strategies to Develop a Suitable Formulation for Inflammatory Skin Disease Treatment.

Authors:  Jiun-Wen Guo; Shiou-Hwa Jee
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.